Advanced biliary tract cancer represents one of the most challenging gastrointestinal malignancies in China, with increasing ...

ASCO GU 2025 had groundbreaking advancements in genitourinary cancer treatments, focusing on prostate cancer, renal cell ...

Daiichi Sankyo Company ($DSKYF) announced an update on their ongoing clinical study. Daiichi Sankyo and Merck Launch New Lung Cancer Study With ...

Final results from the phase 3 CASSANDRA trial presented at the 2025 ASCO Meeting show that the neoadjuvant chemotherapy ...

Please provide your email address to receive an email when new articles are posted on . Current smoking rates at the time of cancer diagnosis varied by sociodemographic and socioeconomic factors.

NDA supported by positive Phase II registration study data in Chinese patients; follows Breakthrough Therapy Designation granted in 2023 —— ...